EPHA7 and prostate neoplasm: We were able to validate previous findings describing frequent hypermethylation events of EPHA7, MGMT and MLH1 in colorectal cancer patients, RARB in prostate tumors, and CASP8 in glioblastoma (Supplementary Figure S13).